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Introduction 
Pulmonary hypertension (PH) is defined as elevated pulmonary artery pressure (PAP) 
secondary to various pathophysiologies causing cor pulmonale and eventually right 
sided heart failure. The WHO classification of PH is based on similarities in 
pathophysiologic mechanisms (table).  
Angiostrongylus (A.) vasorum is an important cause of PH in dogs in endemic areas and 
a most fascinating disease with many open questions despite quite intensive research in 
the past decade. The goal of this presentation is to put A. vasorum into the context of 
PH, to discuss the pathogenesis of the PH caused by it respectively to discuss 
mechanisms that may temper its development, to describe possible courses of disease in 
dogs with A. vasorum associated PH, and to suggest the therapeutic approach in 
critically diseased dogs. 
Table: Classification of pulmonary hypertension* 
Group 1. Pulmonary arterial hypertension (PAH) 
Idiopathic (formerly primary PH, PPH) 
Associated with congenital systemic-to-pulmonic shunts 
Persistent pulmonary hypertension of the newborn 
Associated with drugs, toxins, inflammatory conditions 
Group 2. Pulmonary hypertension associated with left heart disease 
Left ventricular or atrial disease 
Left-sided valvular disease 
Group 3. Pulmonary hypertension associated with respiratory disease and/or hypoxemia 
Interstitial lung disease, e.g. pulmonary fibrosis 
Chronic upper airway obstruction 
Chronic exposure to high altitude 
Group 4. Pulmonary hypertension due to thromboembolic disease 
Primary cardio-vascular lesion, e.g. D. immitis, A. vasorum 
Medical condition predisposing to pulmonary thromboembolism 
Group 5. Miscellaneous 
e.g. neoplasia compressing pulmonary arteries 
 
* WHO classification, Chin and Rubin, 2008, modified and adapted for dog 
 
Angiostrongylus vasorum 
A. vasorum is a ubiquitous metastrongylid heartworm of dogs and related canids. It has 
an indirect life cycle with gastropods (slugs and snails) acting as intermediate hosts. The 
up to 25 mm long adult worms reside in pulmonary arteries and the right ventricle. 
After a prepatent period of 40-60 days eggs are shed in terminal pulmonary arteries. At 
the same time the infection becomes patent, intense immunological reactions against 
eggs and larvae cause severe inflammation in pulmonary vessels (i.e. vasculitis) and 
parenchyma (i.e. pneumonia), with hemorrhage, arterial thrombosis, periarteritis, and 
coalescing granulomata. These pathological changes result in various degrees of 
radiographic changes.  
Clinically, cough and dyspnea are the most common abnormalities, however, in some 
dogs respiratory signs may be completely absent but signs of various other organ 
systems dominate. These may include central nervous system signs, ophthalmic 
inflammation and spontaneous bleeding due to immune-mediated thrombocytopenia or 
disseminated intravascular coagulation. Also, spontaneous or surgery associated 
bleeding may occur without any measurable abnormality in platelet number, platelet 
function (buccal mucosal bleeding time) or coagulation factors (PT, PTT, TT). 
Pulmonary vascular inflammation and pulmonary thrombosis and / or embolism (PTE) 
are important mechanisms of PH, and several recent reports have documented severe 
PH secondary to the infection with A. vasorum. 
  
Parameters that may be important to cause PH 
Despite the pathophysiological expectation that A. vasorum should induce PH in cases 
infected with a high parasitic load respectively in cases with severe pulmonary lesions 
e.g. based on radiographs, the occurrence of PH in A. vasorum is quite unpredictable. 
Parasitic load seems a logical parameter determining development of PH. However, in 
experimental infection, parasitic load did not make an appreciable difference; 
specifically, infection with 50 larvae caused pleural effusion and quite severe 
pulmonary lesion radiographically as well as histopathologically, including wide spread 
thrombosis, but no PH; infection with 500 larvae still did not cause PH. Chronicity may 
play a role; however, arguments against simple chronicity again arise from experimental 
infection, where spontaneous recovery is detectable around 10 weeks after one single 
infection. Rather, repetitive infection with repetitive immunological stimulation may be 
an important factor. An argument in natural infection clearly against chronicity and 
somewhat against repetitive infection is the observation that most clinical cases of 
severe PH seem to occur in quite young dog, often less than 6 months of age, even 
though it may occur at any age. If severe PH is found in a four-month old dog, this dog 
did not have much time for repetitive infection as the prepatent is close to 2 months. 
 
Mechanism of PH in A. vasorum 
In cases with PH, the histopathological findings indicate several mechanisms that may 
cause the PH, i.e. extensive pneumonia with expected hypoxia-induced PH (group 3 
PH), pulmonary fibrosis (group 3), pulmonary artery thrombosis (group 4), and also 
pulmonary artery remodelling like in PAH (group 1).  
The course of the disease in dogs with severe PH may also be quite variable. Some dogs 
make a miraculous recovery within a few days without any detectable PH within 1-2 
weeks. In such cases, pulmonary thrombosis may be the most important cause of PH, as 
it would not be expected that remodeled arteries reverse-remodel so quickly.  
Some dogs die within hours of initiation of therapy; as in some of such dogs pulmonary 
parenchymal lesions radiographically are remarkably less pronounced than in less sick 
dogs, again pulmonary thrombosis, i.e predominantly vascular lesions (as opposed to 
parenchymal lesions with alveolar hypoxia), seems the most plausible important 
pathomechanism of PH. The cause of death in these dogs may not only be related to the 
PTE, but also to therapy. 
Some dogs show an initial recovery over several days or even weeks only to thereafter 
again develop PH, at a time where the parasites are expected to be eliminated and thus 
vasculitis and associated PTE should not any more be present. Interstitial lung disease 
with or without fibrosis would seem a logical explanation for such cases, however, this 
cannot necessarily be found on histopathology. Finally, severe PH may be found in dogs 
that show radiographic abnormalities suspicious of A. vasorum where histopathology 
fails to find an explanation for PH.  
 
Echocardiographic findings in experimentally and naturally infected dogs  
Experimental infection of dogs with A. vasorum allowed studying PTE including 
various echocardiographic and laboratory parameters. Marked pulmonary (vascular) 
abnormalities, including hemorrhage and thrombosis, paralleled by moderate 
hypoxemia with PO2 around 73 mmHg were not sufficient to cause relevant PH nor 2D, 
M-Mode or Doppler echocardiographic changes. 
In a second study the focus was put on newer echocardiographic modalities, i.e. Tissue 
Doppler Imaging (TDI) and contrast echo. A specific goal was to document arterio-
venous shunting during experimental infection and during therapy. It was further 
hypothesized that PH may develop right at the time of treatment, when many worms 
die. In this study, six healthy Beagles were infected with 200 L3 larvae. TDI (pulsed 
wave, RV longitudinal myocardial velocity basal segment), contrast echo with agitated 
saline and pulmonary transit time with SonoVueR, as well as invasive PAP 
measurement were performed pre infection (T0), once 7 to 12 weeks post infection (T1) 
and once during the first five days after parasiticide therapy (T2).  
In the TDI variables analyzed there was a decrease in peak myocardial velocity in 
systole (STDI) and an increase in time to peak systolic contraction (Tpeak) with a median 
STDI of 0.130 m/s (0.123-0.194), 0.128 m/s (0.087-0.173) and 0.117 m/s (0.083-0.152), 
and a median Tpeak of 0.097 ms (0.074-0.149), 0.109 ms (0.102-0.196) and 0.149 ms 
(0.104-0.234) at T0, T1, and T2, respectively. The E/ATDI ratio decreased from T0 1.13 
(0.94-1.55) to T2 0.91 (0.54-1.38). At T0 all dogs showed negative, and at T1 and T2 5 
of 6 dogs showed positive contrast studies for shunts. Median pulmonary transit time 
was 4 beats respectively 2.3 seconds at T0 and no change was observed at T1 and T2. 
Invasively measured PAP slightly increased over time with median sPAP of 24, 25 and 
29 mmHg and dPAP of 10, 11 and 18 mmHg, respectively. Two dogs showed mild PH 
at T2 (sPAP 33 and 30, and dPAP 20 and 25 mmHg); both had E/ATDI <1.  
In conclusion, in dogs with marked pulmonary vascular disease and mild increase in 
PAP, effects on RV function were detectable using TDI but not conventional echo. 
In face of severe pulmonary disease the majority of dogs opened intrapulmonary 
arterio-venous shunts in the absence of relevant PH. Parasiticidal therapy did cause an 
increase in PAP, but not to a clinically relevant degree. 
Echocardiography in naturally infected dogs reveals similar changes, e.g. diastolic TDI 
abnormalities in cases without PH. Most interestingly, some dogs with marked 
radiographic abnormalities but no or mild-moderate PH show arterio-venous shunting 
but some dogs with most severe PH do not. This may, indeed, support the hypothesis 
that the opening of shunts is not just a consequence of pulmonary vascular disease or 
PH, but rather the ability to open such shunts may temper the development of PH. At 
any rate, not in all dogs with pulmonary vascular disease, e.g. caused by A. vasorum, the 
opening of shunts can be demonstrated. As a matter of fact, this has been found already 
many years ago. 
 
Therapeutic approach in dogs with severe pneumonia and / or severe PH 
In view of many similarities between Dirofilaria (D.) immitis and A. vasorum regarding 
PTE and cor pulmonale and in view of the many decades of experience in the treatment 
of D. immits, it is reasonable to extrapolate this knowledge to the treatment of 
complicated cases of A. vasorum. 
There is no safe test to predict the degree of complications, but there is one simple 
factor that can be influenced to decrease the degree of complications, i.e. exercise 
restriction. The logic behind it is the following: more activity  more blood flow in 
peripheral vessels that are damaged by larvae, worms and associated inflammation  
additional lesions like vessel rupture  additional inflammation and fibrosis  
additional PH.   
Specific recommendations in dogs with severe clinical disease and PH thus are:  
- Oxygen cage or nasal oxygen 
- Complete exercise restriction 
- Slow adulticide kill using fenbendazol, 50 mg/kg q24h p.o. for 3-5 days, then a 
few days pause and again fenbendazol 
- Prednisolone, 0.5 mg/kg q12h for 1 week, then q24h for 1 week, then q24h for 1 
week. 
- Pimobendan, 0.2-0-6 mg/kg div. q12h, initially i.v. 
- Viagra, 2 mg/kg q8h p.o. 
- In view of risk of ARDS: infusion with well-adjusted fluid balance, respectively 
rather negative balance, i.e. around 2 ml/kg/h. 
- Sedation if very excited, butorphanol CRI, 0.1-0.2 mg/kg/h 
- Consider theophyllin 
- Clopidogrel  
- Monitor: heart rate, respiratory rate, PH with echo 
Decision about placing the dog on a ventilator:  
- Clinical state (inacceptable dyspnea, weakness) 
- Blood gas analysis PCO2 ≥50 mmHg 
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